Michihiko Wada
InvestorChief Regulatory and Development Officer at Newton Biocapital
Tokyo, Tokyo, Japan
Find your path to Michihiko
282 people in our graph share verified history with Michihiko β schools, employers, funds. One of them is your warm intro.
Kazuhiko NonomuraunlockedMichihiko: together at Kyoto University (1994β1998)
Γ2Michihiko: together at Kyoto University
Michihiko: together at Japan Agency for Medical Research and Development
Γ4Michihiko: together at Bayer HealthCare Japan
About
Michihiko Wada serves as Program Officer for the Strengthening Program for Pharmaceutical Startup Ecosystem at the Japan Agency for Medical Research and Development, and holds the position of Corporate Development & Regulatory Officer at Newton BioCapital Partners. He was involved in obtaining approval for Strensiq from Japan's Ministry of Health, Labour and Welfare on July 3, 2015, the first such approval globally.
Experience
- Japan Agency for Medical Research and DevelopmentProgram Officer, Strengthening Program for Pharmaceutical Startup Ecosystemcurrent2025 β presentTokyo, Tokyo, Japan
- NEWTON BIOCAPITALCorporate Development & Regulatory Officercurrent2024 β presentTokyo
- NEWTON BIOCAPITALAdvisor, Medical & Clinical science s2022 β 2024Tokyo, Japan
- NEWTON BIOCAPITALIndependent Board of Director2020 β 2022Based in Tokyo
- Clinical &Translational Research Center, Keio UniversityProfessor2024 β 2025Tokyo, Japan
- Clinical and Translational Research Center, Keio UniversityProfessor2019 β 2024Shinanomachi 35, Shinjuku-ku, TOKYO
- γ½γγγγ³γ―ε»ε¦ι‘§ε2021 β 2023Tokyo, Japan
- Translational Research Center for Medical InnovationFellow2019 β 2020
- Alexion Pharmaceuticals, Inc.Vice President, Head of R&D Tokyo2014 β 2019
- Foundation of Biomedical and Research InnovationAdviser2012 β 2018
- Alexion Pharmaceuticals JapanHead of Clinical Development2012 β 2017
- Kanazawa Advanced Medical CenterDirector of Personalised Medicine2010 β 2012
- Bayer HealthCare JapanHead of Oncology & Speciality Medicine, Clinical Development2007 β 2010
- Kobe City General HospitalChief Surgeon in HepatoBiliary Pancreatic Surgery2001 β 2007
- Institute of Biomedical and Research Innovation HospitalSurgical Fellow2001 β 2007
- Kyoto University, Dept. of Surgery, Div. of Hepatobiliary Pancreatic Surgery and TransplantationAssistant Professor2000 β 2001
- Vanderbilt University Medical Centerpost-doctoral Fellow in Surgery1998 β 2000
Skills & more
Oncology28Clinical Trials13Clinical Development21Surgery6Clinical Research19Immunotherapy2Team Building1Organizational Effectiveness1Succession Planning1Medical Devices7Life Sciences5Biotechnology4
+12 more
MedicineHospitalsR&DHealthcareDrug DevelopmentRegulatory AffairsGCPResearchStrategic PlanningPersonal DevelopmentStrategyPharmaceutical IndustryFrom Michihiko's professional profile.
Colleagues at Newton Biocapital
Adam Wojacki
Partner at Impera Alfa
Ajit Shetty
Chairman of the Board of NBC I and NBC II at Newton Biocapital
Alain Parthoens
CEO at Newton Biocapital
Chandrika Ubale
Financial Controller at Kilde
Daisuke Morishita
Venture Partner at Newton Biocapital
Danny Gonnissen
COO at Newton Biocapital
Dario Padovani
CFO at Newton Biocapital
Dirk Boogmans
Vice-Chairman and Chairman of the Audit Committee of NBC I and NBC II at Newton Biocapital
Frequently asked questions
- Who is Michihiko Wada?
- Michihiko Wada serves as Program Officer for the Strengthening Program for Pharmaceutical Startup Ecosystem at the Japan Agency for Medical Research and Development, and holds the position of Corporate Development & Regulatory Officer at Newton BioCapital Partners. He was involved in obtaining approval for Strensiq from Japan's Ministry of Health, Labour and Welfare on July 3, 2015, the first such approval globally.
- Where does Michihiko Wada work?
- Michihiko Wada is Chief Regulatory and Development Officer at Newton Biocapital.
- Where did Michihiko Wada go to school?
- Michihiko Wada studied at Kyoto University (PhD, Surgical Oncology).
Same school
Also attended Kyoto University66
Taro InabaManaging Partner at Remiges Ventures, Inc.Kazuhiko NonomuraPartner at Remiges Ventures, Inc.Sunao NishimuraInvestor at E12 Venture Capital, LlcYoshiharu UrunoInvestor at JIC Venture Growth InvestmentsMelody MadhavanAssociate at Cento VenturesKotaro SasamotoManaging Partner at Dentsu Ventures
+ 60 more
Shared employers
Also worked at Japan Agency for Medical Research and Development1
Also worked at NEWTON BIOCAPITAL5
Also worked at γ½γγγγ³γ―22
Elyssa PedoteDirector of Talent at GreycroftAndy SackAdvisor at One Way VenturesKen MiyauchiBoard Director at SoftBank GroupSae NurukiInvestor at Inception Studio CapitalYuni KimLead, Value Creation at Z Venture CapitalTakenori SanamiChief Financial Officer at Icon Ventures
+ 16 more
Also worked at Alexion Pharmaceuticals, Inc.26
Abbie CelnikerInvestor at Third Rock VenturesSeung Hyun Moon, MD, MPAVenture Partner at Adelphi Ventures Management, LlcJustin WilliamsPrincipal at Seae VenturesRomesh SubramanianVenture Partner at Scion Life SciencesChristina BroomesCommercial Advisor at 2Flo VenturesJohn ReyndersChief Data Scientist & Venture Partner at Iaso Ventures
+ 20 more